Lipodystrophy syndrome is a clinically variable and causally heterogeneous disorder[1](#jdi12536-bib-0001){ref-type="ref"}, [2](#jdi12536-bib-0002){ref-type="ref"}.

A 33‐year‐old Japanese woman presented with 'sporadic' congenital partial lipodystrophy (CPLD) associated with mandibuloacral dysplasia (MAD) and an unusual fat maldistribution (Figure [1](#jdi12536-fig-0001){ref-type="fig"}a--d). She had many unique features, such as growth retardation without cognitive dysfunction, bilateral sensorineural deafness and alopecia (Figure [1](#jdi12536-fig-0001){ref-type="fig"}f,g), which coexisted with various progeroid features distinct from those previously described in classical CPLD and/or MAD--A/B types[1](#jdi12536-bib-0001){ref-type="ref"}, [2](#jdi12536-bib-0002){ref-type="ref"}, [3](#jdi12536-bib-0003){ref-type="ref"}, thus suggesting a novel subtype of CPLD or a new causative syndrome.

![(a) Anterior and lateral views of the patient show a generalized absence of subcutaneous fat with a protuberant abdomen, small mandible, small mouth and beaked nose. (b) Close up view of the face and axillary regions. Note the presence of facial lipoatrophy, a lack of hair and the existence of acanthosis nigricans. (c) Multiple calluses are observed in the soles of her feet. (d) A cross‐sectional computed tomography scan at the navel level and thighs. Note the lack of subcutaneous fat and an excessive amount of visceral fat accumulation. (e) T1 weighted magnetic resonance imaging of the sagittal section of the head and upper thorax. Note the presence of subcutaneous adipose tissue in the dorsal cervical region with mandibular hypoplasia. (f) Growth chart. (g) Alopecia areata.](JDI-8-121-g001){#jdi12536-fig-0001}

She was born at full‐term gestation. Her parents first noted fat loss in her limbs during infancy, and she subsequently developed poor overall growth (Figure [1](#jdi12536-fig-0001){ref-type="fig"}f). Deafness was detected at prepuberty. At 10 years‐of‐age, an extensive endocrinological investigation including growth hormones, insulin‐like growth factor‐1 levels, thyroid and adrenal functions, and head computed tomography showed no abnormalities. At 14 years‐of‐age, she was admitted for leg muscle cramps on several occasions. Subcutaneous fat loss was noted predominantly in the face and extremities. An oral glucose tolerance test (1.7‐g glucose/kg) showed normal glucose tolerance (Japan Diabetes Society criteria, 2012) with hyperinsulinemia (homeostasis model assessment of insulin resistance 5.3) and elevated hepatic enzyme levels. At 21 years‐of‐age, dyslipidemia, steatohepatitis on a biopsy and impaired glucose tolerance (glycated hemoglobin 5.7%; National Glycohemoglobin Standardization Program) with marked hyperinsulinemia were noted. A tentative diagnosis of CPLD (Dunnigan--Köbberling variety) was made[1](#jdi12536-bib-0001){ref-type="ref"}, [2](#jdi12536-bib-0002){ref-type="ref"}. When the patient was 33 years‐of‐age, further investigations were carried out (body mass index 15.1 kg/m^2^) and progressively abnormal adipose tissue topography with a paucity of subcutaneous fat in her entire body including the palms of her hands and soles of her feet was noted (Figure [1](#jdi12536-fig-0001){ref-type="fig"}a--c). Abdominal computed tomography and whole body magnetic resonance images confirmed visceral fat accumulation (visceral fat area/subcutaneous fat area = 217.1/13.3 cm^2^ at the navel level) with mandibular hypoplasia without clavicular hypoplasia (Figure [1](#jdi12536-fig-0001){ref-type="fig"}d,e). She showed hirsutism, acanthosis nigricans, alopecia areata (Figure [1](#jdi12536-fig-0001){ref-type="fig"}b,g) and dysmenorrhea (due to polycystic ovary syndrome based on the low sex hormone‐binding globulin, normal free testosterone, elevated luteinizing hormone/follicle‐stimulating hormone ratio and a polycystic pattern on magnetic resonance imaging \[T1, T2WI/fat suppression imaging\]). Low plasma leptin/adiponectin levels were observed (3.6 ng/mL and 2.4 μg/mL, respectively). An oral glucose tolerance test revealed a diabetic pattern (fasting plasma glucose 103, 2 h 230 mg/dL) with hyperinsulinemia (fasting immunoreactive insulin 23.8, 2 h 226.9 μU/mL), and severe insulin resistance was confirmed by the glucose clamp technique (glucose infusion rate 4.32 mg/kg/min at an infusion rate of 1.5 mU/kg/min; healthy control 10.9 ± 4.2). A sequence analysis was carried out to establish genetic causes; however, no key mutations for CPLD or MAD (*LMNA* gene encoding lamin A and C, peroxisome proliferator‐activated receptor gamma, *perilipin*, cell death‐inducing fiffa‐like effector C, *zinc metalloprotein STE24* and *PTRF* gene encoding cavin‐1)[1](#jdi12536-bib-0001){ref-type="ref"}, [2](#jdi12536-bib-0002){ref-type="ref"} were identified.

Potential causative factors included the regional differences in fat deposition as a result of the variable expression of unknown genetic mutations, and the severity of insulin resistance, potentially leading to various metabolic derangements. Recently, seven atypical MAD cases with lipodistrophy were reported by Shastry *et al*.[4](#jdi12536-bib-0004){ref-type="ref"}; two female patients shared some phenotypic similarities with our case, including deafness, a short stature and mandible hypoplasia of unknown genetic origin. The other five patients were males with hypogonadism. This is the first such report in Asia, including Japan. The unique clinical manifestations of this case are herein reported because of its rarity.
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